All In Biotech

Free tool

FAERS Monitor: Trintellix

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 204447 or its brand name (Trintellix, Vortioxetine Hydrobromide). Reports on generic versions are filed under their own applications.

Reports

17,188

Serious

8,272

48% of reports

Hospitalization

2,949

Death reported

1,016

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea2,284
  • fatigue1,225
  • drug ineffective1,165
  • headache1,075
  • anxiety1,053
  • vomiting1,036
  • suicidal ideation969
  • off label use948
  • insomnia942
  • dizziness904
  • diarrhoea850
  • pruritus806
  • asthenia792
  • depression786
  • feeling abnormal686

Reports by year received

View as table
YearReports
20121
201410
2015116
20161,444
20172,154
20181,866
20192,005
20201,668
20211,553
20221,419
20231,274
20241,442
20251,323
2026913

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,036,971 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
suicidal ideationSignal96913.112.310,732
anxietySignal1,0534.54.32,933
insomniaSignal9424.34.12,440
depressionSignal7864.24.01,956
nauseaSignal2,2843.53.44,307
feeling abnormalSignal6863.53.31,240
vomitingSignal1,0362.72.51,130
astheniaSignal7922.62.4778
pruritusSignal8062.62.4784
dizzinessSignal9042.22.1619
headacheSignal1,0752.12.0636
fatigue1,2251.91.8565
diarrhoea8501.61.5203
off label use9481.31.279
drug ineffective1,1651.11.08

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.